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Objectives. The present study examines the incidence of aortic
complications (dissection, marked dilation requiring surgery or
progressive moderate to severe aortic regurgitation) and their
relation to clinical features and sortie root morphology in patients
with the Marfan syndrome .
Background. Considerable phenotypic variability exists in the
Marian syndrome, and the prospective prediction of the risk for
aortic complications in individual patients remains elusive .
Methods. One 'tundred thirteen patients with the Marian
syndrome
underwent
anthropometric and echocardlographic
evaluation and were followed-up for 49 ± 24 (mean * SD)
months. Aortic root dilation was defined as localized when con-
fined to the sinuses of Valsdva (based on two-dimensional
edeocardiographic confidence limits utilizing age and body size)
and generalized if dilation additionally involved the supraaortic
ridge and proximal ascending aorta .
Results. Aortic root dilation was present in 80 % of patients and
A clinical hallmark and the major cause of morbidity and
premature death in the Marian syndrome is aortic root
dilation and associated aortic regurgitation, dissection and
rupture (1) . Although echocardiographic evidence of aortic
root dilation is present in 60% to 80%5 of patients with the
Marfan syndrome (2-5), there exists considerable variation
in the nature and severity of aortic involvement (6,7) and,
hence, clinical course. Furthermore, data concerning the
prognostic significance of phenotypic features in the Marian
syndrome are limited. Factors identified thus far to be
predictive of an increased likelihood of aortic dissection
include aortic root size >60 mm (8) and a family history of
dissection (9), whereas clinical evidence of aortic regurgita-
tion is associated with reduced survival (10),
In patients without the Marfan syndrome but with severe
aortic regurgitation due to idiopathic aortic root dilation, we
have previously noted more severe left ventricular bypertro-
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was localized in 2S% and generalized in 51% . Aortic compika.
tions occurred during follow-up in none of 23 patients with normal
initial aortic size, in 2 (656) of 32 patients with initially localized
dilation end in 19 (33%) of 58 patients with generated dilation
(p < 0.0005), Complications were associated with larger initial
aortic sine (p < 0 .00005), higher systolic blood pressure (p <
0.005), height (p < 0 .05), aortic growth rate (p c 0.05) and older
age (p < 0.01). The Only independent predictor of Sortie compli-
cations was initial aortic root sine (p < 0.006) . However, when
aortic size, one of the indications for surgical referral, was
excluded from analyses, the only independent predictor of aortic
complications was generalized aortic dilation (p < 0 .005).
Couciustorts. The present study indicates that generalized
ortic root dila ion is a potent marker of m Increased risk for
subsequent aortic complications in Marfm syndrome.
(J Am
Cog
CardoI 1993;22:1470-6)
phy and dysfunction in those patients with generalized aortic
dilation (extending from the sinuses of Valsalva into the
supraaortic ridge and proximal ascending aorta) than in
those with localized dilation (confined to the sinuses of
Valsalva) (11) . Preliminary observations in 51 adult patients
with the Marfan syndrome indicated that localized dilation
may be associated with a more benign prognosis (12). This
report extends these observations to a larger series of
patients with a longer duration of follow-up .
Methods
Study group. The study group comprised 113 consecu-
tive patients with the Marian syt:drums who were evaluated
at the New York Hospital-Cornell Medical Center and
followed-up for an average of 49 } 24 months . Patients were
studied under a protocol approved by the Committee on
Human Rights in Research in 1979 and at regular intervals
thereafter. The diagnosis of the Marfan syndrome was
established in all patients adhering to established diagnostic
criteria (13) . Patients who had undergone proximal aortic
surgery before the initial evaluation or who had no follow-up
information available were excluded from analysis . There
were 84 adults and 29 children and adolescents (age <16
years in girls and < 18 years in boys), with an average age at
0733-1077.9315bAD
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initial evaluation of 28 ± 15 years (range 6 months to 66
years). Fifty-one patients were female, and 62 were male .
Eighty-two patients studied were probands or affected
members in 30 families . Nine patients appeared to represent
disease due to a new mutation . Two patients were adoptees,
and 20 were probands whose families had not undergone
evaluation . Seventy-nine patients (70%) started or continued
taking beta-adrenergic blocking agents or other blood
pressure-lowering medications at the time of initial evalua-
tion, whereas 34 patients took no medications .
Aortic complications were defined as aortic dissection,
performance of proximal aortic surgery (for dissection or as
prophylaxis against dissection, based on current recommen-
dations [81, or for symptomatic severe aortic regurgitation)
or as progression to moderate to severe (3 to 4±14) aortic
regurgitation during follow-up .
Clinical evaluallon. All patients underwent physical ex-
amination, including anthropometric evaluation . Standard
measurements included height, wei[ht, arm span and upper]
lower segment ratio. An upper/lower segment ratio in adults
of <0.85 in whites or <0.78 in blacks was considered
abnormal. Age-related nomograms were used in children
(14). Arachnodactyly was considered present if either the
Steinberg thumb sign (15) or the Walker-Murdoch wrist sign
(16) was present . Slit lamp examination to detect ectopia
lentis was performed in 90 patients.
Echo atrdioqprophle evaluation. All patients underwent
echocardiographic evaluation at the time of initial evalua-
tion. Echocardiographic evidence of mitral valve prolapse
constituted at least a 2-nun posterior mitral displacement
during late systole or a 3-mm displacement throughout
systole on M mode tracings, which was confirmed by billow-
ing of one or both mitral leaflets superior to the plane of the
mitral annulus in two-dimensional parasternal long-axis
views (17,18) .
Using a commercially available review center (Digison-
ics), detailed measurements of the aortic root were made in
two-dimensional parasternal tong-axis views at four levels
(Fig. 1): annulus, sinuses of Valsalva, supraaortic ridge and
proximal ascending aorta. Measurements were made at
end-diastole using the leading edge technique on up to four
cycles and averaged. The presence of aortic root dilation
was determined using nomograms based on age and body
size (19). The dimension at the level of the sinuses of
Valsalva was also expressed as the ratio of observed diam-
eter to thai expected based on a regression equation involv-
ing age and body surface area (19). Dilation was termed
localized if confined to the sinuses of Valsalva and general-
ized if enlargement extended into the supraaortic ridge and
proximal ascending aorta (Fig . 2) (11) . The rate of aortic
growth was determined by dividing either the absolute or
obscrvedlexpectcd change in aortic diameter between the
initial and most recent echocardiograms by the duration of
follow-up in years. Aortic regurgitation was graded using
pulsed Doppler jet length criteria (20).
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lire 1. Schematic lUustration of the aortic root as seen in a
two-dimensional echocardi prrasternal log-axis view.
Measurement of the aortic dieter was performed at the ac s
(1), sinuses of Valsalva (2) . supraaortic ridge (3) and proximal
ascending aorta (4). AO = aorta; LA = left atrium; LV - left
ventricle . (Reproduced from Roman et al. (19) with permission from
the American lownat of Cardiology .)
Statistical analyses. Data were stored and analyzed with
the Crunch 4 Statistical Package (Crunch Software Corpo-
ration) . Data are presented as mean values with I SD as the
index of dispersion and were compared using the Impaired
Student r test. The relation between continuous variables
was compared using linear regression analysis . Indepen-
dence of relation was tested using logistic regression . Differ-
ences between categoric variables were tested using chi-
square analysis (with the Bonferroni correction for multiple
comparisons). Comparisons between the three groups cate-
gorized according to aortic morphology were made using
analysis of variance followed by the Scheme test for analysis
of multiple comparisons .
Results
Clinical cmmcwi~ The phenotypic features of pa-
tients with the Marian syndrome are listed in Table I . High
prevalences of skeletal, ocular and cardiac abnormalities
were found in both children and adults, and their frequencies
did not differ between the two groups. Because the ratio of
arm span to height is commonly greater than unity in normal
subjects (4,21), the presence of an arm span at least 3 in .
(7.62 cm) greater than the height was also determined as a
more specific indication of excessive length (22).
Gender-related differences are examined in Table 2 . Ab-
solute aortic sizes were larger in male patients, but these
differences were eliminated by indexing for body surface
area. Scoliosis was more commonly seen in female patients
(72% vs. 50%, p < 0.05), but prevalence rates of other
skeletal abnormalities did not differ . Mural valve prolapse
tended to be more common in girls and women on initial
evaluation (67% vs. 48%, p = 0.06) and was detected
significantly more frequently on follow-up evaluation (70%
vs. 40%, p < 0.005).
of aortic root fun. Aortic root dilation was
present in 90 (80%) of 113 patients studied and was more
commonly due to generalized (58 [51%] of 113) than local-
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ire 2. A, Two-dimensional echtxardioMph demonstrating lo-
calized nortic dilation in a 31yeaNdman . Aortic diameter is 4.4cm
at the siamatee of Valsalva and 2,8 cm at the supraaortic ridge .
B, Two-dimensional echocardiogram emonstrating generalized
aortic dilation in a 30-year old man. Aortic diameter is 4.4 cm at the
sinuses of Valsalva and 3.9 cm at the supraaortic ridge . Depth
markers are 1 cm apart in both panels. AAo = ascending aorta ;
other abbreviations as in Figure 1 .
ized (32 [28%] of 113) dilation. The prevalence rates of the
two patterns did not differ between children and adults .
Features of patients without aortic dilation are compared
with those of patients with the two patterns of dilation in
Table 3. There were no significant differences between the
three groups with regard to age, body size, ocular findings
and duration of follow-up . Although there tended to be a
stepwise increase in the prevalence of skeletal abnormalities
Run the group with no dilation to the groups with localized
andd generalized dilation, none of these differences achieved
statistical significance (all p > 0.2). The patients with gener-
alized dilation were more likely to be male than female (p <
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Table 1.
Phenotypic Features of 113 Children and Adults With the
Marfan Syndrome
There were no significant differences between groups . Values presented
are percent of patients or mean value t I SD .
0.05 vs. nondilation and localized dilation combined) and
were more likely to be taking medication than were those
patients without aortic dilation .
The annual aortic growth rate was higher among patients
with generalized dilation than in those with localized dilation
(0.11 ± 0 .09 vs. 0.07 ± 0.07, p < 0.05) but did not differ
statistically from that of the smaller group without initial
aortic dilation (0.08 ± 0.09). The presence of any degree of
aortic regurgitation was more common in patients with
generalized dilation than in those with localized (36% vs .
9%, p < 0.05) or no (0%, p < 0.005) dilation. The prevalence
of mitral valve prolapse was statistically similar (44% to
60%) in the three groups .
During follow-up, three patients whose aortic root diam-
eter had been at the upper limit of normal on initial evalua-
tion developed mild aortic dilation after intervals of 2, 3 and
4 years. Two men with localized dilation progressed to
generalized dilation, associated in one with progressive
aortic regurgitation . Two additional patients with localized
dilation developed mild aortic regurgitation during follow-
up. In contrast, among patients with generalized dilation,
eight developed new mild aortic regurgitation, four had
progression from mild to moderate aortic regurgitation, and
one had progression from moderate to severe aortic regur-
gitation,
Prediction of aortic complications . Aortic complications
occurred in 21 patients (19%) during follow-up . Four pa-
tients, all with generalized aortic dilation at baseline, devel-
oped aortic dissection during follow-up . Three underwent
corrective surgery, and one died before operation could be
performed . Sixteen patients underwent proximal aortic sur-
gery for severe dilation (dissection was suspected preoper-
atively in two but not confirmed at operation) . Although all
16 patients had generalized dilation at the time of operation,
one patient had localized dilation at his initial evaluation that
became generalized during 6 years of follow-up in the setting
Children
(n = 29)
Adults
(n = 84)
Arachnodactyly 79 68
Pectus excavatum 41 46
Pectus carinatum
38 29
Scoliosis
48 64
Arm span/height ratio
1 .02 ± 0 .03 1 .04 ± 0.14
Arm span/height 2:3 in . (a7.6 cm)
142 31
Upper/lower segment ratio
0 .86 ± 0 .11 0.86 ± 0.07
Abnormal segment ratio 64 43
Ectopia lentil 70 64
Mitral valve prolapse 62
55
Aortic root dilation
76 81
Localized
31 27
Generalized 45 54
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Values presented are mean value ± I SD or percent .
of progressive aortic regurgitation. One patient with local-
	
developed in patients with generalized dilation, representing
ized dilation had progression to asymptomatic severe aortic one third of this group .
regurgitation. Thus, 20 (95%) of 21 aortic complications The clinical features of the 92 patients without aortic
Table 3. Comparison of Clinical Features of Patients With the Marfan Syndrome Grouped by
Aortic Root Morphology
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*p < 0.05 versus nondilation and localized d
ilation . tp < 0.005 versus nondilation
. Values presented are mean
value ± I SD or percent.
Table 2 . Comparison of Phenotypic Features in Male and Female Patients With the
Marfan Syndrome
Male
Patients
in = 62)
Female
Patients
in = 51)
p
Value
Age (y)
29 ± 16
27 ± 15 NS
Height (in .) 72±9 66±9
<0.001
(cm) 183 ± 23 168 ± 22
Systolic blood pressure (mm Hg) 128±19 123±21
NS
Diastolic blood pressure (Mai 11g) 74 ± 13 73 ± 11
NS
Aortic size
Annulus (cm) 2 .6 ± 0 .5 2.4 ± 0.6 < 0 .05
(eWN)
1 .4 ± 0 .4
1 .5 ± 0 .3 NS
Sinuses of Valsalva (cm) 4 .2 ± 1 .0 3 .7 ± 0 .9 < 0 .005
(cm/m °
)
2 .3 ± 0 .5 2.3 ± 0 .5 NS
Supraaortic ridge (cm) 3 .5 ± IJ 3.0 ± 0 .9 < 0.01
(cm/m 2
)
1 .9
± 0 .5 1 .8 ± 0 .5 NS
Proximal ascending aorta (cm) 3 .4 ± 1 .1 2.9 ± 0 .8 < 0 .01
(cin.) ) 1 .8 ± 0 .5 It ± 0 .4 NS
Aortic dilation 85 73 NS (0 .09)
Aortic growth (emlyr) 0 .09 ± 0.09 0.09 2: 0 .08 NS
Mitral valve prolapse
48 67 NS (0 .
Ectopia lentis
63 69 NS
Arachnodactyly 66 78 NS
Pectus excavatum 43 47 NS
Pectus carinatum 34 29
NS
Scoliosis
50 72 < 0 .05
Abnormal segment ratio
41 57 NS
Arm span/height 2:3 in . (a7 .5 cm) 36 22 NS
Nondilation
(n = 23)
Localized
Dilation
(n = 32)
Generalized
Dilation
(n = 58)
Age (yr)
29 ± 17
27 ± 16
27 ± 14
Male
39
47
66*
Height (in .)
69 ± 8
67 ± 11 71 ± 9
(cm)
175 ± 21 170 ± 28
180 ± 22
Weight (lb)
152 ± 46
144 ± 51
151 ± 45
(kg)
69±21
66±23
69±21
127 ± 20
Systolic blood pressure
(mm Hg)
120 ± 19
129 ± 19
Diastolic blood pressure
(mm Hg)
71 ± 11
74 ± 9
75 ± 13
Upper/lower segment ratio
0.86 ± 0 .07
0.88 ± 0.10
0 .85 ± 0 .07
Arachnodactyly
65
69
75
Pectus excavatum
22
31
36
Pectus carinatum
30
44
51
Ectopia lentis
61
65
67
With medical therapy
39
69
83 1,
50 ± 20
Duration of follow-up (mo)
47±28
49±28
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Table 4 .
Comparison of Clinical Features of Patients With the Marfan Syndrome With and Without
Aortic Complications During Follow-Up
Values presented am mean value ± I SD or percent . BP = blood pressure.
complications are contrasted with those of patients with
complications in Table 4. Patients developing complications
were older and slightly taller . Systolic blood pressure and,
especially, pulse pressure were higher in those with compli-
cations, most likely reflecting the higher prevalence of
associated aortic regurgitation . Otherwise there were no
differences in age, gender or duration of follow-up . A trend
toward more common use of pharmacologic therapy, primar-
ily with beta-blocking agents, in the group with as opposed
to that without complications (86% vs, 66% p = NS)
reflected the impact on management decisions of the greater
prevalence and severity of aortic dilation in the former group
(see below). Furthermore, among the patients with general-
dilation, aortic complications occurred in 30% of those
who were not and in 33% of those who were taking medica-
tion . Family history of aortic dissection, sudden death or
prophylactic aortic surgery at an early age (<40 years old)
tended to be more common among patients with aortic
complications (21 % vs. 8%, p = 0.1).
Echocardiographic findings in the groups with and with-
out aortic complications are presented in Table 5 . Patients
developing aortic complications had significantly larger
aortic dimensions at all levels (including the annulus and
proximal ascending aorta). Aortic growth rate was higher
in the group with complications. The detection of aortic
regurgitation at most recent follow-up or before surgery
was also more common among those developing complica-
lions .
Those features that differed significantly between the
groups with and without complications at initial evaluation
(using the diameter at the sinuses of Valsalva as a represen-
tative measure of aortic size) were entered into a logistic
regression model to predict the development of complica-
tions. The only independent predictor of aortic complica-
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tions was initial aortic root size (p < 0.005). Because
absolute aortic size was one of the indications for surgical
referral, initial aortic size was excluded from an alternative
analysis, The only independent predictor of aortic compli-
cations was generalized aortic dilation (p < 0.005) .
Discussion
Prognosis. Life expectancy in the Marfan syndrome is
significantly reduced as a consequence of aortic dilation and
its complications. Of 257 patients with Marfan syndrome
seen at The Johns Hopkins Hospital before 1972, the mean
Table S . Comparison of Echocardiographic Findings in Patients
With Marfan Syndrome With and Without Aortic Complications
During Follow-Up
Values presented are mean value t I SD or number (%) of patients .
No Aortic
Complications
(n = 92)
Aortic
Complications
(n = 21)
p
Value
Age (yr)
26 ± 15 36 ± 14
* 101
Male
52 67
NS
Height (in .) 69 ± 10
72 t 4 * 0 .05
(cm)
175 ± 26 183 ± 11
Weight (lb)
148 ± 50
159 ± 30
NS
(kg)
67 ± 23
72 ± 14
Systolic BP (mm Hg)
123
	
18 139 ± 21 < 01005
Diastolic BP (mm Hg)
74 t 11 M ± 15 NS
Pulse pressure (mm Hg)
49 13 69±21 <0.001
uppernower segment ratio
0.86 0.08
0.86 ± 0.08 NS
Arachnodactyly (%) 73
60 NS
Pectus carinatum ( )
29 45 NS
Pectus excavatum M
47 35 NS
Ectoph lentis (%)
67 57 NS
With medical therapy 66 86 NS
Duration of follow-up (me)
47 t 25 55±18 NS
No Aortic
Complications
(n = 92)
Aortic
Complications
(n = 21)
p
Value
Sinuses of Valsalva (cm) 3.7 t 0.8 5 .1 t 0.8
< 0.00005
Sinuses of Valsalva
(observedlexpected)
1 .14 t 0.2 1 .56 ± 0.2 < 0.00005
Supraaortic ridge (cm) 2.9 ± 0.7 4 .6 t 0.9 < 0.00005
Aortic growth (cm/yr) 0.09 t 0.08 0.14 t 0.05 < 0.05
Aortic regurgitation
(no .) < 0.0005
Mild
11(12) 7 (33)
Moderate
6 (7) 3(15)
Severe 1 (1)
8(38)
Mitral valve prolapse 57 57 NS
Aortic morphology (no.)
< 0
.0005
Nondilation 23(25) 0
Localized dilation
30(33) 2 (10)
Generalized dilation
39 (42) 19 (90)
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survival in life table analyses was -40 years in men and -50
years in women
(1) . Disease of the aorta accounted for 80%
of known causes of death (1) . The , rage age at death was
35 years in 81 patients followed-up for a mean of 99 months
at The Cleveland Clinic, including 35 patients undergoing
surgical intervention (10) . With the advent and refinement of
aortic surgery in the setting of and as prophylaxis against
aortic dissection (8,23), life expectancy has undoubtedly
been prolonged in individual patients . Recent data from The
Johns Hopkins Hospital indicate a 1% hospital mortality rate
and 10-year actuarial survival rate of 76% in 100 patients
who underwent composite graft repair of the aortic root and
valve (24) .
Risk stratification . The considerable variability in the
phenotypic expression of the Marfan syndrome has led to
attempts to identify subjects at greatest risk for the early
development of aortic complications . Of 50 consecutive
patients undergoing aortic surgery reported by Gott et al . (8),
14 had dissection involving the ascending aorta . Although
the mean aortic diameter was similar in the groups with and
without dissection, the aortic diameter was 2:6 cm in all but
one patient with dissection . Pyeritz (9) subsequently de-
scribed 40 patients with the Marfan syndrome who under-
went surgery for aortic dissection, 15 of whom had an aortic
root diameter :s6 cm, and compared them with 27 patients
undergoing surgery who did not have dissection. A
family history of dissection or sudden death before the age of
40 years was the only characteristic that distinguished the
two groups (9) . Of 81 patients with the Marfan syndrome
seen over 3 decades at The Cleveland Clinic, including 35
patients who underwent aortic surgery, the presence of a
diastolic murmur or roentgenographic cardiomegaly on ini-
tial evaluation was a marker for early death (10) .
The present study confirms the importance of age, aortic
regurgitation and aortic size as markers for development of
aortic complications . However, the current use of aortic
diameter as a rationale for recommending elective surgery
undercuts its value as a prospective marker for risk. Fur-
thermore, aortic dissection may occur in the absence of
marked aortic root dilation (7,9) . Although the annual rate of
change in aortic size was greater in patients with aortic
complications, growth rate among individual patients was
quite variable, as others (25,26) have noted . Growth rate
ranged from -0 .1 to 0 .3 cm/year in patients with complica-
tions and from 0 .0 to 0.3 cm/year in patients without com-
plications . A trend toward more frequent complications in
patients with a family history of major complications before
age 40 years was
also observed . Although the present study
was not designed to address the efficacy of beta-blockade
therapy in preventing aortic complications, the similarity in
complication rates between the groups with and without
medical therapy does not support a beneficial impact of
pharmacologic therapy. Resolution of this important issue
awaits the publication of controlled trials .
Generalized aortic dilation proved to be a powerful
categoric marker for risk in our patients . All but 1 of 21 end
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points occurred within the group with
generalized dilation .
This finding is analogous to our previous observation in
aortic regurgitation associated with idiopathic aortic root
dilation wherein, despite the similar presence of severe
aortic regurgitation, those patients with generalized dilation
had evidence of a more profound impact on left ventricular
size and function and, hence, clinical course than did pa-
tients with localized dilation (I1) .
possible mechanisms. Several potential mechanisms
might explain the association of generalized dilation with
more rapidly progressive disease. Generalized dilation in-
volves enlargement of the supraaortic ridge at the level of
commissural attachment . Thus, leaflet coaptation may be
compromised, thereby promoting aortic regurgitation. In
fact, aortic regurgitation was present at baseline in 36% of
patients with generalized dilation and was moderate or
severe in almost half of these . Additionally, the larger aortic
dimensions associated with generalized dilation result in an
increase in wall tension, thereby predisposing to the ob-
served faster rate of growth of aortic size . Whether gener-
alized dilation might also reflect a quantitatively more severe
degree of underlying cystic medial necrosis or different
mutations in fibrillin (27) cannot be determined from the
present study .
Although two patients manifested a shift from localized to
generalized dilation during follow-up, it seems unlikely that
localized dilation represents an earlier stage of aortic in-
volvement . The mean ages of the three groups classified
according to aortic morphology were virtually identical, as
was duration of follow-up . In addition, the prevalence of
localized and generalized dilation was similar in adults and
children. Likewise the presence of aortic regurgitation as a
mechanical factor precipitating transformation of localized
dilation into generalized dilation is unlikely in view of the
fact that <40% of patients with generalized dilation had
Doppler echocardiographic evidence of aortic regurgitation .
The male predominance in the group with generalized dila-
tion is intriguing and is reminiscent of the male predomi-
nance observed in aortic regurgitation due to non-Marfan
etiologies, particularly that due to idiopathic aortic dilation
(11) and in congenital bicuspid aortic valve, which is com-
monly associated with aortic dilation independent of hemo-
dynamic abnormalities (28) .
Study limitations and conclusions. The exclusion of pa-
tients already having undergone proximal aortic surgery
represents a potential limitation of the present study . How-
ever, review of preoperative contrast aortograms and de-
scriptions of intraoperative inspection of the aortic root
suggest that most, if not all, of these patients would have fit
our echocardiographic definition of generalized aortic dila-
tion, thereby strengthening study conclusions . In addition,
the current practice of referring patients for aortic surgery
when the aortic root diameter reaches 6 cm, even in the
absence of dissection or symptoms, somewhat distorts the
more traditional reliance on clinical end points, such as
cardiac death or dissection, or both
. Although quantitative
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and qualitative abnormalities of gene expression may ulti-
mately provide the most accurate markers for risk, initial
analyses of fibrillin mutations in patients with the Marfan
syndrome suggest that there will be a large number of rare
mutations rather than a small number that are common
enough to be individually useful as predictors of complica-
tions among patients with the Marfan syndrome (29,30) .
Thus, until the predictive value of molecular-phenotypic
correlations is clarified, the pattern of aortic dilation appears
to provide a useful, noninvasive marker of a significantly
increased likelihood of progressive aortic disease in the
Marfan syndrome .
We thank Virginia Burns for invaluable assistance in preparation of the
manuscript .
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